search
Back to results

Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery (DRIPS)

Primary Purpose

Post-operative Urinary Retention

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Tamsulosin
Placebo
Sponsored by
Anand Rughani, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Post-operative Urinary Retention

Eligibility Criteria

50 Years - 85 Years (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria

  • Male patient age 50 - 85 years
  • Undergoing elective spine surgery at least 5 days after enrollment
  • Preop visit done at office practice

Exclusion Criteria:

  • Currently on tamsulosin or other alpha-adrenergic blocking drug
  • Allergy to tamsulosin
  • Allergy to lactose
  • Serious or life-threatening allergy to sulfa drugs
  • Emergent procedure
  • History of spinal trauma, spinal infection or spinal cord tumor
  • Pre-existing indwelling urinary catheter
  • History of orthostatic hypotension or current orthostatic hypotension
  • History of prostate, urethral or bladder surgery
  • Renal failure
  • Non-English speaking
  • Unable to provide informed consent

Sites / Locations

  • Maine Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Tamsulosin

Placebo

Arm Description

Subjects in this arm will receive tamsulosin 0.4 mg/day for five days prior to surgery and two days after surgery.

Subjects in this arm will receive a placebo capsule identical in appearance to the tamsulosin capsule, for five days prior to surgery and two days after surgery.

Outcomes

Primary Outcome Measures

Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention
Postoperative urinary retention was defined as the need for any postoperative urinary catheterization for acute retention. Per hospital protocol, failure to void 6 hours after surgery or development of bladder discomfort required bladder scan. If bladder volume exceeded 300 cc, catheterization was performed.

Secondary Outcome Measures

Length of Stay
Length of hospital stay
Number of Participants With or Without Postoperative Urinary Retention Based on Preoperative Post-void Residual
Was post-void residual greater than 50 cc when measured at the preoperative office visit associated with postoperative urinary retention?

Full Information

First Posted
September 28, 2016
Last Updated
January 27, 2022
Sponsor
Anand Rughani, MD
Collaborators
MaineHealth
search

1. Study Identification

Unique Protocol Identification Number
NCT02919436
Brief Title
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
Acronym
DRIPS
Official Title
Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
March 2016 (undefined)
Primary Completion Date
January 2020 (Actual)
Study Completion Date
November 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Anand Rughani, MD
Collaborators
MaineHealth

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Randomization (1:1) of male patients, over age 50, undergoing elective spine surgery to tamsulosin versus a placebo.
Detailed Description
Postoperative urinary retention (POUR) is a common complication following certain surgical operations. While much is known about the innervation and neural regulation of bladder emptying and storage, the cause of urinary retention after surgery is not fully understood. Early research has indicated that a small dose of tamsulosin (Flomax®), a commonly used medication approved to treat urinary symptoms in men with benign prostatic hypertrophy, may reduce the incidence of POUR. Urinary retention is a prevalent issue in patients undergoing spinal surgery, leading to patient discomfort and prolonged length of stay. We hypothesize that the use of perioperative tamsulosin in patients undergoing spinal surgery will decrease the incidence of POUR. The study is a prospective, double-blind, randomized, placebo-controlled trial. Subjects will be randomized 1:1 to receive either oral tamsulosin 0.4 mg or placebo, taken once each evening, beginning 5 days prior to surgery and continuing through the first postoperative day. The primary endpoint is met when the patient is able to spontaneously empty their bladder post-operatively, or needs to be catheterized with either a straight or indwelling urinary catheter for post-operative urinary retention, whichever occurs first.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-operative Urinary Retention

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
610 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Tamsulosin
Arm Type
Experimental
Arm Description
Subjects in this arm will receive tamsulosin 0.4 mg/day for five days prior to surgery and two days after surgery.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Subjects in this arm will receive a placebo capsule identical in appearance to the tamsulosin capsule, for five days prior to surgery and two days after surgery.
Intervention Type
Drug
Intervention Name(s)
Tamsulosin
Other Intervention Name(s)
Flomax, Flomaxtra, Contiflo XL, Urimax
Intervention Description
Active drug
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Lactose-filled capsules identical to active drug
Primary Outcome Measure Information:
Title
Number of Patients Who Undergo Postoperative Catheterization for Urinary Retention
Description
Postoperative urinary retention was defined as the need for any postoperative urinary catheterization for acute retention. Per hospital protocol, failure to void 6 hours after surgery or development of bladder discomfort required bladder scan. If bladder volume exceeded 300 cc, catheterization was performed.
Time Frame
Within 2 days after surgery
Secondary Outcome Measure Information:
Title
Length of Stay
Description
Length of hospital stay
Time Frame
0-7 days after surgery
Title
Number of Participants With or Without Postoperative Urinary Retention Based on Preoperative Post-void Residual
Description
Was post-void residual greater than 50 cc when measured at the preoperative office visit associated with postoperative urinary retention?
Time Frame
Within 2 days after surgery

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Male patient age 50 - 85 years Undergoing elective spine surgery at least 5 days after enrollment Preop visit done at office practice Exclusion Criteria: Currently on tamsulosin or other alpha-adrenergic blocking drug Allergy to tamsulosin Allergy to lactose Serious or life-threatening allergy to sulfa drugs Emergent procedure History of spinal trauma, spinal infection or spinal cord tumor Pre-existing indwelling urinary catheter History of orthostatic hypotension or current orthostatic hypotension History of prostate, urethral or bladder surgery Renal failure Non-English speaking Unable to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anand Rughani, MD
Organizational Affiliation
MaineHealth
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maine Medical Center
City
Portland
State/Province
Maine
ZIP/Postal Code
04102
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery

We'll reach out to this number within 24 hrs